First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT – Get Free Report)’s share price fell 0.3% on Tuesday . The stock traded as low as GBX 1,418.84 ($17.66) and last traded at GBX 1,430.60 ($17.81). 10,238 shares were traded during mid-day trading, an increase of 686% from the average session volume of 1,303 shares. The stock had previously closed at GBX 1,435.50 ($17.87).
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Price Performance
The firm has a market cap of £4.23 billion and a price-to-earnings ratio of -1,300.55. The company has a current ratio of 9.42, a quick ratio of 9.27 and a debt-to-equity ratio of 0.04. The stock’s fifty day moving average price is GBX 1,462.13 and its 200-day moving average price is GBX 1,443.20.
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Company Profile
Forbidden Technologies plc develops and owns cloud-based video technology in the United Kingdom, North America, and internationally. It offers Forscene, a cloud based video post-production and publishing platform with various applications, such as editing, adding closed caption, graphics, metadata fast, remote viewing, collaboration, and publishing content.
Further Reading
- Five stocks we like better than First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation
- Best Stocks Under $5.00
- Silicon Motion Proves That AI in Motion Stays in Motion
- With Risk Tolerance, One Size Does Not Fit All
- Undervalued UnitedHealth Group Won’t Be For Long
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- The 5 Stocks Most Sold By Insiders This Year
Receive News & Ratings for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation and related companies with MarketBeat.com's FREE daily email newsletter.
